For Sponsors & CROs

A dependable execution partner for Phase I–IV studies, medical device investigations and real-world evidence in India.

Why India, why Ethica

Local execution expertise for global-quality studies

Running a clinical study in India offers access to large, treatment-naive patient populations, experienced investigators and cost-efficient operations — but only when execution is managed by people who know the system from the inside.

Ethica Research gives sponsors and CROs one accountable partner for feasibility, site selection, regulatory approvals, patient recruitment, site management, monitoring and data. Whether you need a full-service CRO or a reliable site network to complement your own team, we adapt to your operating model.

Phase I–IVClinical study support
ICH-GCPAligned SOPs & training
12Therapeutic areas covered
1 dayResponse to every enquiry
Problems we solve

Built around the issues that delay studies

Slow study start-up

Feasibility and site activation often drag on for months. We return data-backed feasibility in 5–7 business days and run ethics and regulatory submissions in parallel.

Recruitment shortfalls

Most delayed trials miss enrollment targets. We build recruitment plans around patient registries, physician referral networks and ethics-approved community outreach from day one.

Regulatory complexity

CDSCO, CTRI and ethics committee requirements change often. Our regulatory specialists manage every submission and query end-to-end.

Limited visibility

Sponsors deserve to know where their study stands. Weekly dashboards track enrollment, data entry, open queries and deviations — no surprises.

Operating principles

How we work with sponsors

Ethics before everything

Participant safety, valid informed consent and data integrity are never traded for speed. Our processes are built around them.

Investigator-led quality

Experienced principal investigators and GCP-certified coordinators run every site, supported by an independent QA function.

Rapid, transparent start-up

Parallel submissions, pre-negotiated site agreements and standard budgets help studies go live sooner.

Partnership, not outsourcing

We co-own timelines with you, escalate early and stay accountable from first contact to final report.

Start the conversation

Request a confidential feasibility assessment

Tell us about your study. A senior member of our clinical operations team will review it and respond within one business day.

  • Confidential review under NDA
  • Response within one business day
  • Direct PI and site assessment

Sponsor FAQs

How quickly can you deliver feasibility?

We usually deliver a site-by-site feasibility assessment with realistic enrollment projections within five to seven business days of receiving a protocol synopsis under NDA.

Do you support medical device investigations?

Yes. We support pilot, pivotal and post-market clinical investigations of medical devices and in-vitro diagnostics in line with the Medical Devices Rules, 2017.

Can you work with overseas sponsors and CROs?

Absolutely. We regularly act as the local execution partner for international sponsors and CROs, supporting regulatory submissions, site management and monitoring in India.

What does your quality system look like?

We operate under a documented quality management system with SOPs, training records, internal audits, CAPA management and regular mock inspections at sites.

Request site feasibility

Share a few details about your study. Everything you send is treated as confidential, and we are happy to sign an NDA first.

PDF, DOC or DOCX — max 8 MB. Please do not upload patient data.